Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Omnicell, a provider of medication-use solutions which include complete automation systems for the central pharmacy, has reported revenues of $56.29m for the third quarter ended 30 September 2010, compared to $53.96m for the same period in 2009.
Subscribe to our email newsletter
Omnicell has posted a net income of $1.28m for the third quarter 2010, or $0.04 per diluted share, compared to $854,000m, or $0.03 per diluted share, for the comparable period in 2009.
For the nine months ended 30 September 2010, Omnicell has posted revenue of $165.14m, compared to $158.8m for the year ago period.
For the nine months ended 30 September 2010, Omnicell has posted a net income of $4.22m, or $0.13 per diluted share, compared to net loss of $112,000, or $0 loss per diluted share, for the year ago period.
Omnicell president, CEO and chairman Randall Lipps said that Omnicell enjoyed success in the marketplace during the third quarter with orders across their customer base.